Titre : Agents séquestrants

Agents séquestrants : Questions médicales fréquentes

Termes MeSH sélectionnés :

Diglycerides
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Agents séquestrants : Questions médicales les plus fréquentes", "headline": "Agents séquestrants : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Agents séquestrants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-03", "dateModified": "2025-04-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Agents séquestrants" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Utilisations spécialisées de produits chimiques", "url": "https://questionsmedicales.fr/mesh/D020313", "about": { "@type": "MedicalCondition", "name": "Utilisations spécialisées de produits chimiques", "code": { "@type": "MedicalCode", "code": "D020313", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chélateurs", "alternateName": "Chelating Agents", "url": "https://questionsmedicales.fr/mesh/D002614", "about": { "@type": "MedicalCondition", "name": "Chélateurs", "code": { "@type": "MedicalCode", "code": "D002614", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Agents chélateurs du calcium", "alternateName": "Calcium Chelating Agents", "url": "https://questionsmedicales.fr/mesh/D065096", "about": { "@type": "MedicalCondition", "name": "Agents chélateurs du calcium", "code": { "@type": "MedicalCode", "code": "D065096", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500.204" } } }, { "@type": "MedicalWebPage", "name": "Agents chélateurs du fer", "alternateName": "Iron Chelating Agents", "url": "https://questionsmedicales.fr/mesh/D007502", "about": { "@type": "MedicalCondition", "name": "Agents chélateurs du fer", "code": { "@type": "MedicalCode", "code": "D007502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500.410" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sidérophores", "alternateName": "Siderophores", "url": "https://questionsmedicales.fr/mesh/D017262", "about": { "@type": "MedicalCondition", "name": "Sidérophores", "code": { "@type": "MedicalCode", "code": "D017262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500.410.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Sidérophores", "alternateName": "Siderophores", "url": "https://questionsmedicales.fr/mesh/D017262", "about": { "@type": "MedicalCondition", "name": "Sidérophores", "code": { "@type": "MedicalCode", "code": "D017262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.832.500.410.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Agents séquestrants", "alternateName": "Sequestering Agents", "code": { "@type": "MedicalCode", "code": "D064449", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xueli Cao", "url": "https://questionsmedicales.fr/author/Xueli%20Cao", "affiliation": { "@type": "Organization", "name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China." } }, { "@type": "Person", "name": "Yu Xiao", "url": "https://questionsmedicales.fr/author/Yu%20Xiao", "affiliation": { "@type": "Organization", "name": "Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China." } }, { "@type": "Person", "name": "Erin Huiting", "url": "https://questionsmedicales.fr/author/Erin%20Huiting", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA." } }, { "@type": "Person", "name": "Dong Li", "url": "https://questionsmedicales.fr/author/Dong%20Li", "affiliation": { "@type": "Organization", "name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China." } }, { "@type": "Person", "name": "Jie Ren", "url": "https://questionsmedicales.fr/author/Jie%20Ren", "affiliation": { "@type": "Organization", "name": "State Key Laboratory for Biology of Plant Diseases and Insect Pests, Ministry of Agriculture, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100081, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Water-in-oil emulsions enriched with alpha-linolenic acid in diacylglycerol form: Stability, formation mechanism and in vitro digestion analysis.", "datePublished": "2022-05-13", "url": "https://questionsmedicales.fr/article/35609461", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.foodchem.2022.133201" } }, { "@type": "ScholarlyArticle", "name": "Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohort.", "datePublished": "2024-02-13", "url": "https://questionsmedicales.fr/article/38349899", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pmed.1004338" } }, { "@type": "ScholarlyArticle", "name": "Low and high temperatures promote docosahexaenoic acid accumulation in Crypthecodinium sp. SUN by regulating the polyunsaturated fatty acid synthase pathway and the expression of saturated fatty acid preferred diacylglycerol acyltransferases.", "datePublished": "2023-10-07", "url": "https://questionsmedicales.fr/article/37813314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biortech.2023.129850" } }, { "@type": "ScholarlyArticle", "name": "Editing a rice CDP-DAG synthase confers broad-spectrum resistance.", "datePublished": "2023-08-28", "url": "https://questionsmedicales.fr/article/37648632", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tplants.2023.08.011" } }, { "@type": "ScholarlyArticle", "name": "Functions and substrate selectivity of diacylglycerol acyltransferases from Mortierella alpina.", "datePublished": "2023-07-27", "url": "https://questionsmedicales.fr/article/37498333", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00253-023-12694-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://questionsmedicales.fr/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Agents séquestrants", "item": "https://questionsmedicales.fr/mesh/D064449" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Agents séquestrants - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Agents séquestrants", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Agents séquestrants", "description": "Comment diagnostiquer une intoxication aux métaux lourds ?\nQuels examens pour évaluer l'efficacité d'un agent séquestrant ?\nQuels symptômes indiquent un besoin d'agents séquestrants ?\nComment identifier une carence nutritionnelle ?\nQuels signes d'overdose d'agents séquestrants ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Diglycerides&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Agents séquestrants", "description": "Quels symptômes d'une carence en fer ?\nComment reconnaître une toxicité au plomb ?\nQuels signes d'une carence en calcium ?\nQuels symptômes d'une intoxication au mercure ?\nComment se manifeste une carence en potassium ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Diglycerides&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Agents séquestrants", "description": "Comment prévenir les carences nutritionnelles ?\nQuelles mesures pour éviter l'exposition aux métaux lourds ?\nComment réduire le cholestérol par l'alimentation ?\nQuels aliments riches en calcium pour la prévention ?\nComment éviter les effets secondaires des séquestrants ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Diglycerides&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Agents séquestrants", "description": "Quels agents séquestrants pour le cholestérol ?\nComment fonctionnent les agents séquestrants ?\nQuels sont les effets secondaires des agents séquestrants ?\nComment administrer un agent séquestrant ?\nQuels agents séquestrants pour les métaux lourds ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Diglycerides&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Agents séquestrants", "description": "Quelles complications d'une surconsommation d'agents séquestrants ?\nQuels risques d'une utilisation prolongée ?\nComment les agents séquestrants affectent-ils l'absorption des médicaments ?\nQuelles complications liées à l'intoxication au plomb ?\nQuels effets à long terme des agents séquestrants ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Diglycerides&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Agents séquestrants", "description": "Quels facteurs augmentent le risque de carences ?\nQui est à risque d'intoxication au mercure ?\nQuels groupes sont vulnérables aux carences en calcium ?\nQuels comportements augmentent le risque d'intoxication aux métaux ?\nQuels facteurs influencent l'absorption des nutriments ?", "url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Diglycerides&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux métaux lourds ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et urinaires peuvent détecter la présence de métaux lourds." } }, { "@type": "Question", "name": "Quels examens pour évaluer l'efficacité d'un agent séquestrant ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses biochimiques peuvent mesurer les niveaux de nutriments ou toxines." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin d'agents séquestrants ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs abdominales ou des troubles digestifs peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Comment identifier une carence nutritionnelle ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent révéler des carences en vitamines ou minéraux." } }, { "@type": "Question", "name": "Quels signes d'overdose d'agents séquestrants ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des nausées, vomissements ou diarrhées peuvent signaler une overdose." } }, { "@type": "Question", "name": "Quels symptômes d'une carence en fer ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, pâleur, essoufflement et vertiges sont des symptômes courants." } }, { "@type": "Question", "name": "Comment reconnaître une toxicité au plomb ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des troubles neurologiques et des anémies peuvent survenir." } }, { "@type": "Question", "name": "Quels signes d'une carence en calcium ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des crampes musculaires, des engourdissements et des troubles de l'humeur peuvent apparaître." } }, { "@type": "Question", "name": "Quels symptômes d'une intoxication au mercure ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des tremblements, des troubles de la mémoire et des problèmes de vision peuvent se manifester." } }, { "@type": "Question", "name": "Comment se manifeste une carence en potassium ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des faiblesses musculaires, des palpitations et des troubles du rythme cardiaque peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir les carences nutritionnelles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et variée est essentielle pour éviter les carences." } }, { "@type": "Question", "name": "Quelles mesures pour éviter l'exposition aux métaux lourds ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments contaminés et utiliser des filtres à eau peut réduire l'exposition." } }, { "@type": "Question", "name": "Comment réduire le cholestérol par l'alimentation ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Consommer des fibres solubles et limiter les graisses saturées aide à réduire le cholestérol." } }, { "@type": "Question", "name": "Quels aliments riches en calcium pour la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les produits laitiers, les légumes verts et les noix sont de bonnes sources de calcium." } }, { "@type": "Question", "name": "Comment éviter les effets secondaires des séquestrants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Prendre les agents séquestrants avec suffisamment d'eau et suivre les recommandations médicales." } }, { "@type": "Question", "name": "Quels agents séquestrants pour le cholestérol ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les résines comme le cholestyramine sont utilisées pour réduire le cholestérol sanguin." } }, { "@type": "Question", "name": "Comment fonctionnent les agents séquestrants ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils se lient aux substances dans l'intestin, empêchant leur absorption dans le sang." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des agents séquestrants ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des effets comme des ballonnements, des nausées et des troubles digestifs peuvent survenir." } }, { "@type": "Question", "name": "Comment administrer un agent séquestrant ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont généralement pris par voie orale, souvent mélangés à des liquides." } }, { "@type": "Question", "name": "Quels agents séquestrants pour les métaux lourds ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des agents comme l'EDTA sont utilisés pour traiter les intoxications aux métaux lourds." } }, { "@type": "Question", "name": "Quelles complications d'une surconsommation d'agents séquestrants ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des carences nutritionnelles et des troubles digestifs." } }, { "@type": "Question", "name": "Quels risques d'une utilisation prolongée ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une utilisation prolongée peut causer des déséquilibres électrolytiques et des carences." } }, { "@type": "Question", "name": "Comment les agents séquestrants affectent-ils l'absorption des médicaments ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire l'absorption de certains médicaments, diminuant leur efficacité." } }, { "@type": "Question", "name": "Quelles complications liées à l'intoxication au plomb ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, rénales et cardiovasculaires peuvent survenir." } }, { "@type": "Question", "name": "Quels effets à long terme des agents séquestrants ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des effets à long terme peuvent inclure des carences nutritionnelles et des troubles métaboliques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de carences ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation déséquilibrée, des maladies chroniques et des régimes restrictifs augmentent le risque." } }, { "@type": "Question", "name": "Qui est à risque d'intoxication au mercure ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes consommant régulièrement des poissons contaminés sont à risque élevé." } }, { "@type": "Question", "name": "Quels groupes sont vulnérables aux carences en calcium ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées, les femmes enceintes et les végétariens peuvent être plus vulnérables." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque d'intoxication aux métaux ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Travailler dans des environnements contaminés ou utiliser des produits non réglementés augmente le risque." } }, { "@type": "Question", "name": "Quels facteurs influencent l'absorption des nutriments ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, la santé digestive et les interactions médicamenteuses influencent l'absorption." } } ] } ] }

Sources (89 au total)

Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohort.

Emulsifiers are widely used food additives in industrially processed foods to improve texture and enhance shelf-life. Experimental research suggests deleterious effects of emulsifiers on the intestina... This study included 92,000 adults of the French NutriNet-Santé cohort without prevalent cancer at enrolment (44.5 y [SD: 14.5], 78.8% female, 2009 to 2021). They were followed for an average of 6.7 ye... In this large prospective cohort, we observed associations between higher intakes of carrageenans and mono- and diglycerides of fatty acids with overall, breast and prostate cancer risk. These results... ClinicalTrials.gov NCT03335644....

Low and high temperatures promote docosahexaenoic acid accumulation in Crypthecodinium sp. SUN by regulating the polyunsaturated fatty acid synthase pathway and the expression of saturated fatty acid preferred diacylglycerol acyltransferases.

Low (15 °C) and high (35 °C) temperatures significantly increased DHA as a percentage of total fatty acids (TFAs) to 43.6 % and 40.46 %, respectively (1.28- and 1.18-fold of that at 25 °C, respectivel...

Maternal plasma diacylglycerols and triacylglycerols in the prediction of gestational diabetes mellitus.

To define the lipidomic profile in plasma across pregnancy, and identify lipid biomarkers for gestational diabetes mellitus (GDM) prediction in early pregnancy.... Case-control study.... Tertiary referral maternity unit.... Plasma samples from 100 GDM and 100 normal glucose tolerance (NGT) women, divided into a training set (GDM first trimester = 50, GDM second trimester = 40, NGT first trimester = 50, NGT second trimest... Plasma samples were collected in the first (11... Gestational diabetes mellitus.... In both the GDM and NGT group, lyso-glycerophospholipids were down-regulated, whereas ceramides, sphingomyelins, cholesteryl ester, diacylglycerols (DGs) and triacylglycerols (TGs) and glucosylceramid... Our results have proposed new lipid biomarkers for the first trimester prediction of GDM, independent of ethnicity and BMI....